← Open Payments lookup

LACEY PODY: Open Payments

NPI 1629581517 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,662 in 94 payments from 18 companies in 2025. Trend: 2023 $1,496 · 2024 $1,700 · 2025 $1,662

Food & beverage: $1,551Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$238
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$200
ABBVIE INC.23$198
Teva Pharmaceuticals USA, Inc.9$192
Supernus Pharmaceuticals, Inc.9$163
Lundbeck LLC5$104
Neurocrine BioSciences, Inc.4$89
Corium, LLC4$87
Takeda Pharmaceuticals U.S.A., Inc.4$68
Janssen Pharmaceuticals, Inc4$65

Products named: REXULTI, CAPLYTA, VRAYLAR, Qelbree, INGREZZA, Azstarys, TRINTELLIX, SPRAVATO.

Industry payments across AL — which companies pay providers there.